Sign in

CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475617627
Phone
(617) 231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 4 Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 8-K Event Shareholder vote results
  10. 8-K Event Regulation FD disclosure · Other events
  11. 4 Option exercise Director acquired 1,070 shares (option exercise)
  12. 144 Insider Sale of Securities
  13. SCHEDULE 13G Stake Statement of Beneficial Ownership
  14. SCHEDULE 13G/A Stake Statement of Beneficial Ownership
  15. 8-K Event Executive or director change
  16. SCHEDULE 13G Stake Statement of Beneficial Ownership
  17. 10-Q Report Quarterly Report
  18. 8-K Event Results of operations · Regulation FD disclosure
  19. ARS Other Annual Report to Security Holders
  20. DEFA14A Proxy Proxy Materials

Page 2 of 28 · 548 filings